Sever Pharma Solutions
Sever Pharma Solutions is a dedicated CDMO specializing in high potent drug development, controlled-release systems, and polymer-based delivery solutions. With a history dating back to the 1970s, the company offers end-to-end services including formulation development, manufacturing, and research, with facilities in Malmö, Sweden, and Putnam, CT, USA. They focus on innovative pharmaceutical solutions to improve drug stability, efficacy, and patient outcomes, and are recognized for their advancements in controlled-release systems and high-potent drug manufacturing.
Industries
Nr. of Employees
medium (51-250)
Sever Pharma Solutions
Patents
Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device
US-11872284-B2
View DetailsIntrauterine device and method for reducing the rate of diffusion of active ingredients in said device by adding inert particulates to a polymeric coating
US-9775905-B2
View Details
Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device
US-11872284-B2
View DetailsIntrauterine device and method for reducing the rate of diffusion of active ingredients in said device by adding inert particulates to a polymeric coating
US-9775905-B2
View DetailsProducts
Polymer-based implants and inserts (controlled release)
Implantable and insertable polymer-based drug delivery systems designed for long-acting, controlled release of potent APIs.
Vaginal rings (controlled-release)
Polymer-based intravaginal rings configured for sustained release of APIs for local or systemic prophylactic or therapeutic use.
Pre-filled syringes and auto-injector assemblies
Aseptically filled pre-filled syringes and assembled auto-injectors for high-potent injectable drugs, with integrated assembly and packaging services.
Solid oral dosage forms manufactured via HME
Oral tablets and capsules produced from hot melt extruded amorphous solid dispersions to enhance solubility and dissolution of poorly water-soluble APIs.
Polymer-Based
Development services for technologically demanding polymer-based delivery systems, handling feasibility screening, polymer excipient sourcing, and complex drug-polymer interactions.
Polymer-Based Dosage Forms
Polymer and extrusion development of delivery systems that can be produced robustly against affordable costs at any scale.
Polymer-based implants and inserts (controlled release)
Implantable and insertable polymer-based drug delivery systems designed for long-acting, controlled release of potent APIs.
Vaginal rings (controlled-release)
Polymer-based intravaginal rings configured for sustained release of APIs for local or systemic prophylactic or therapeutic use.
Pre-filled syringes and auto-injector assemblies
Aseptically filled pre-filled syringes and assembled auto-injectors for high-potent injectable drugs, with integrated assembly and packaging services.
Solid oral dosage forms manufactured via HME
Oral tablets and capsules produced from hot melt extruded amorphous solid dispersions to enhance solubility and dissolution of poorly water-soluble APIs.
Polymer-Based
Development services for technologically demanding polymer-based delivery systems, handling feasibility screening, polymer excipient sourcing, and complex drug-polymer interactions.
Polymer-Based Dosage Forms
Polymer and extrusion development of delivery systems that can be produced robustly against affordable costs at any scale.
Services
Formulation and process development for polymer-based and controlled-release dosage forms, small-scale prototyping, proof-of-concept extrusion and scale-up support for clinical and commercial programs.
Analytical characterization and method development for HME formulations and solid dispersions using microscopy, thermal analysis, spectroscopy, dissolution testing and chromatographic assays.
Regulatory strategy, dossier support and guidance for drug–device combination products, Quality by Design implementation, QTPP, risk assessments and design control documentation for US and EU submissions.
GMP manufacturing including high-containment HPAPI suites, hot melt extrusion at clinical and commercial scale, aseptic fill and finish for syringes, injection molding and assembly/packaging for auto-injectors and rings.
Formulation and process development for polymer-based and controlled-release dosage forms, small-scale prototyping, proof-of-concept extrusion and scale-up support for clinical and commercial programs.
Analytical characterization and method development for HME formulations and solid dispersions using microscopy, thermal analysis, spectroscopy, dissolution testing and chromatographic assays.
Regulatory strategy, dossier support and guidance for drug–device combination products, Quality by Design implementation, QTPP, risk assessments and design control documentation for US and EU submissions.
GMP manufacturing including high-containment HPAPI suites, hot melt extrusion at clinical and commercial scale, aseptic fill and finish for syringes, injection molding and assembly/packaging for auto-injectors and rings.
Expertise Areas
- Controlled-release polymer-based drug delivery
- High-potency API (HPAPI) development and containment
- Hot-melt extrusion formulation and scale-up
- Aseptic sterile manufacturing for high-potent injectables
Key Technologies
- Hot melt extrusion (HME)
- Twin-screw extrusion
- Single-screw extrusion
- Co-extrusion
News & Updates
Sever Pharma Solutions will participate in BIO International in Boston, MA, USA, from June 16-19, 2025.
The company was acknowledged for its advancements in controlled-release systems and polymer-based drug delivery solutions in the Medicon Valley cluster.
Acknowledged as a key innovator in pharmaceutical manufacturing and research within Medicon Valley.
Sever Pharma Solutions will participate in BIO International in Boston, MA, USA, from June 16-19, 2025.
The company was acknowledged for its advancements in controlled-release systems and polymer-based drug delivery solutions in the Medicon Valley cluster.
Acknowledged as a key innovator in pharmaceutical manufacturing and research within Medicon Valley.